Skip to main content
2023 Midyear Clinical Meeting & Exhibition Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certfified Pharmacy Executive Leader (CPEL)
Certfified Pharmacy Executive Leader (CPEL)
Integrated Informatics Institute
Integrated Informatics Institute
Back
Handout

Educational Sessions

Intensive Studies for Recertification

Board Certification Activities

New Kids on the Block: The Future of Pediatric Drug Formulations

Monday, December 4, 2023
4:00 PM – 5:00 PM  
Location: ACC North, Room 256, 200 Level
CE Credits 1.00 contact hours
Activity #: 0204-0000-23-244-L01-P
Activity Type: Application-based
Target Audience: Pharmacist, Board-Certified Pharmacist
NOTE: This session is part of the Live Intensive Studies and Clinical Sessions packages. All attendees may attend these thought-provoking and highly educational sessions. However, if you are board certified, you must purchase the package(s) for your specialty to receive the recertification assessment and claim the recertification credit.

Current oral pediatric dosage forms are almost exclusively oral solutions and suspensions. Pharmaceutical companies are developing new solid oral dosage forms (such as mini tablets) for pediatric patients, which will allow for flexible dosing and swallowability. This session will review the current challenges of administering oral medications to children and then describe novel oral dosage forms for children, including a discussion of the literature behind their safe use in children as young as infants. The advantages of these novel dosage forms, such as extended shelf life and patient tolerability will be discussed in addition to their challenges, such as managing dose flexibility with devices. Cases will illustrate examples of problematic medications and discuss how newer dosage forms may help solve these problems.

This activity is approved for Board Certified Pediatric Pharmacy Specialist (BCPPS) recertification credit.

Learning Objectives:

  • List common administration problems with currently available oral and intravenous dosage forms for children.
  • Describe newer solid oral dosage forms for children, including their advantages and the new challenges that they present.
  • Recommend the safe use of newer oral dosage forms when they become commercially available.
  • Choose an appropriate dosage form for a patient based on disease and patient-specific considerations.